Skip to main content

Table 6 Comparison of "degree of severity" of the MRS and its domains. Prevalence in percent (%) and 95% confidence interval (in parenthesis) in the population sample studied in the respective regions (see methods)

From: The Menopause Rating Scale (MRS) scale: A methodological review

  Europe North America Latin America Asia
Total score     
No, little (0–4) 28.8 (+/-1.3) 28.0 (+/-2.3) 31.0 (+/-1.7) 40.2 (+/-3.0)
Mild (5–8) 21.9 (+/- 1.2) 23.9 (+/-2.2) 20.2 (+/-1.4) 27.5 (+/-2.8)
Moderate (9–16) 25.1 (+/-1.2) 25.7 (+/-2.2) 26.2 (+/-1.6) 22.8 (+/-2.6)
Severe (17+) 24.3 (+/- 1.2) 22.5 (+/-2.1) 22.7 (+/-1.5) 9.5 (+/-1.8)
Psychological domain     
No, little (0–1) 35.4 (+/-1.4) 36.8 (+/-2.4) 36.8 (+/-1.6) 41.3 (+/-3.1)
Mild (2–3) 21.8 (+/-1.2) 21.9 (+/-2.1) 21.9 (+/-1.4) 25.4 (+/-2.7)
Moderate (4–6) 19.5 (+/-1.1) 18.7 (+/-2.0) 18.7 (+/-1.4) 21.3 (+/-2.6)
Severe (7+) 23.4 (+/-1.2) 22.5 (+/-2.1) 22.5 (+/-1.7) 12.0 (+/-2.0)
Somato-vegetative domain     
No, little (0–2) 39.5 (+/-1.4) 37.9 (+/-2.4) 42.1 (+/-1.8) 46.8 (+/-3.1)
Mild (3–4) 22.6 (+/-1.2) 25.6 (+/-2.2) 19.4 (+/-1.4) 27.0 (+/-2.8)
Moderate (5–8) 24.2 (+/-1.2) 24.3 (+/-2.2) 25.6 (+/-1.6) 20.8 (+/-2.5)
Severe (9+) 13.7 (+/-1.0) 12.1 (+/-1.7) 12.9 (+/-1.2) 5.4 (+/-1.4)
Urogenital domain     
No, little (0) 34.3 (+/-1.3) 33.4 (+/-2.4) 28.2 (+/-1.8) 55.6 (+/-3.1)
Mild (1) 17.2 (+/-1.1) 17.0 (+/-2.0) 18.6 (+/-1.1) 18.6 (+/-2.4)
Moderate (2–3) 23.0 (+/- 1.2) 24.2 (+/-2.2) 21.8 (+/-1.3) 17.0 (+/-2.3)
Severe (4+) 25.6 (+/-1.2) 25.4 (+/-2.2) 31.4 (+/-1.3) 8.8 (+/-1.8)